Solid Biosciences Inc (SLDB) stock is lower by -48.64% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives SLDB stock a score of 40 out of a possible 100.
That rank is influenced by a short-term technical score of 9. SLDB's rank also includes a long-term technical score of 14. The fundamental score for SLDB is 96. In addition to the average rating from Wall Street analysts, SLDB stock has a mean target price of $10.30. This means analysts expect the stock to climb 444.97% over the next 12 months.
SLDB has an Overall Score of 40. Find out what this means to you and get the rest of the rankings on SLDB!
Solid Biosciences Inc (SLDB) stock is down -3.08% while the S&P 500 is higher by 0.06% as of 10:16 AM on Wednesday, Dec 8. SLDB is lower by -$0.06 from the previous closing price of $1.95 on volume of 1,479,455 shares. Over the past year the S&P 500 has risen 26.67% while SLDB is lower by -48.64%. SLDB lost -$0.85 per share in the over the last 12 months.
Click Here to get the full Stock Report for Solid Biosciences Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
